Stock Events

Stock Events

SAB Biotherapeutics (SABS) Q3 2024 Earnings

8AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-1.15

-0.78

-0.42

-0.06

Details

Expected EPS

-1.146667

Actual EPS

-0.79

Surprise EPS

0.36

Surprise Percent

+31.1%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.79 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.